Recently, the liver micronucleus (MN) assay using young adult rats with repeated administrations has been investigated by employing a new method without partial hepatectomy or in situ collagenase perfusion as the repeated dose liver MN (RDLMN) assay by Narumi et al in order to investigate the possibility of the RDLMN assay using young adult mice instead of rats and the feasibility of employing some genotoxicity assays along with the RDLMN assay as a combination test, two genotoxic carcinogens (N,N assay, peripheral blood (PB) MN assay and comet assay using the liver and kidney were concurrently performed as a combination test. DEN showed positive responses to all endpoints except MN induction in comet assay yielded negative responses for both organs at both sampling times. PHE yielded negative ble method to be integrated into the general repeated toxicity test along with the combination assays, i.e., comet assay or PB MN assay, which would help in risk assessment for carcinogenicity by comparing the results of combination assays with each other.
INTRODUCTION
In vivo micronucleus (MN) assays using bone marrow or peripheral blood (PB) are commonly performed for the assessment of genotoxicity. However, these assays are considered to be insensitive to certain carcinogens, such as unstable mutagens or promutagens with shortlived metabolites, because such carcinogens cannot reach Cliet et al atives, various organs such as the liver, stomach, skin, colon, lung, bladder and testis have been reported to be used for the MN assay since the proliferating cell population in any organ can be used to evaluate MN induction (Morita et al key site of xenobiotic metabolism and one of the major targets of carcinogenesis, which means that in vivo genotoxicity assays using the liver are very important. However, liver cells replicate relatively slowly in adult animals, so an MN assay using the liver requires the stimulation of cell division by performing partial hepatectomy (PH) et al , et al rats need to be used without any additional physical or chemical treatment (Suzuki et al et al., in situ collagenase perfusion is indispensable to isolate hepatocytes. Both PH and in situ collagenase perfusion are laborious and require high-level skills, which has prevented the liver MN assay from becoming popular as a screening genotoxicity assay.
--the integration of in vivo genotoxicity assays into general toxicity tests to reduce the number of experimental animals. Based on this concept, there have been several reports on integrating the PB MN assay, comet assay or Pig-a gene mutation assay into the repeated toxicity tests (Hamada et al et al et al liver MN assay using adult animals without any additional physical or chemical treatment, because MN can be accumulated in the liver for a prolonged period by repeating treatment.
et al method to isolate hepatocytes for preparing liver MN specimens simply by incubation of sliced tissue of a small portion of the liver with collagenase solution instead of laborious in situ perfusion, which never hinders the prepmethod, they conducted liver MN assays using young adult rats with repeated treatments as the repeated dose liver MN (RDLMN) assay to investigate the possibility of integrating the liver MN assay into general subacute toxicity tests (Narumi et al et al., - of examples for the concept that species variation in car-fore, the liver MN assay using mice could be important to estimate the carcinogenic potential of chemicals for mice particularly when there are some differences of metabolism and other biological kinetic parameters between rats N,N-diethylnitrosoamine (DEN) and cisplatin) and a nongenotoxic carcinogen (phenobarbital (PHE)) were administered icity assays, i.e. the liver MN assay, PB MN assay and comet assay using the liver and kidney were concurrently tigated whether the RDLMN assay using mice is as feasible as using rats, and evaluated the effectiveness of performing the combination assays for the risk assessment of carcinogenicity.
MATERIALS AND METHODS

Animals
dark cycle and allowed free access to food and drinking water. During the course of this experiment, we followed the recommendations set forth by our institutional animal care and use committee for the handling, maintenance, i.p. administration was used in the carcinogenicity studies of cisplatin as well as most of the in vivo genotoxicity assays reported to date, which was based on the fact that this medicine is administered intravenously to -the liver of mice, because this chemical did not show a -
Liver MN assay
Narumi et al tissues were rinsed with cold Hank's balanced salt solu--lated by pipetting and forced through a cell strainer temperature until analysis.
sion was mixed with an equal volume of acridine orange slides were observed by fluorescence microscopy at of micronucleated HEPs (MNHEPs) were recorded based on the observation of 2,000 parenchymal HEPs per animal.
PB MN assay
ble to the bone marrow MN assay and is a much simwhen the combination assay is conducted, it is important to choose a simpler method to increase throughput. Blood samples were collected on the last day of the study. Each animal was restrained while the tail was pricked observation of 2,000 reticulocytes per animal.
Comet assay
in vivo alkaline comet assay was performed according to the method of the Japanese Center for the Valida-ly, the livers and kidneys were excised, and the whole liver sample other than left lateral liver lobe and whole kidney sample were minced in chilled mincing solution ++ -and Mg ++ erate a single-cell suspension and then the suspension a light-proof condition. 
RESULTS
Liver MN assay
--cies induced by PHE were about the same as the vehicle control level.
--
No mortality or clinical signs were observed in any animals except those treated with PHE, some of which weight gains of other treatment groups were similar to the vehicle control level.
Comet assay
intensity. vehicle control (Dunnett's test). . 2 (B) . However, the exact reason is not clear, since an appropriate evaluation of the relationship between the MN frequency and cell proliferation may require information on the cell proliferation at the exact time when chromosome damage occurs to be fixed as MN during the period of administration, not at the sampling time.
Fig
comet tail in some in vitro studies, which were often conducted with a method using pretreatment of gamma-ray or mutagen for raising the control level, since they prevent phoresis step of the comet assay by cross-linking between et al.,
were reported for in vivo liver or kidney comet assays of et tail, while another report showed an increase (Nesslany induction in mice liver is greater than in rat liver when our study is compared with the data produced by Narumi et al the historical control data in the bone marrow MN assay reported by Krishna et al. (2000) showed that the positive control (cyclophosphamide) range or standard deviation to this report, it might be said that the individual variability of positive response is greater in mice than in rats, and that it is not clear, but this is one of the reason for a relatively large variation observed in our study. assay using mice along with the comet assay or PB MN assay as a combination study can be integrated into the general repeated toxicity test, and that the genotoxicity of the chemicals tested can be evaluated by comparing the results of those integrated combination assays with each genotoxin but is unstable, the RDLMN assay could detect its genotoxicity, even if the PB MN assay fails to detect it. Moreover, the positive response found in the RDLMN age by consideration of the positive result in the comet and liver shows a negative response in the comet assay, the RDLMN assay using mice combined with multiple genotoxicity assays could improve risk assessment for carcinogenicity, when integrated into the general repeated toxicity test, and that a further study using chemicals whose carcinogenicity differ between rats and mice might reveal intriguing information on this assay.
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